_version_ 1783741221134401536
author Maruko, Ichiro
Okada, Annabelle A.
Iida, Tomohiro
Hasegawa, Taiji
Izumi, Takahiko
Kawai, Moeko
Maruko, Ruka
Nakayama, Makiko
Yamamoto, Akiko
Koizumi, Hideki
Tamashiro, Tamaki
Terao, Nobuhiro
Wakugawa, Sorako
Mori, Ryusaburo
Onoe, Hajime
Tanaka, Koji
Wakatsuki, Yu
Itagaki, Kanako
Kasai, Akihito
Ogasawara, Masashi
Sekiryu, Tetsuju
Shintake, Hiroaki
Sugano, Yukinori
author_facet Maruko, Ichiro
Okada, Annabelle A.
Iida, Tomohiro
Hasegawa, Taiji
Izumi, Takahiko
Kawai, Moeko
Maruko, Ruka
Nakayama, Makiko
Yamamoto, Akiko
Koizumi, Hideki
Tamashiro, Tamaki
Terao, Nobuhiro
Wakugawa, Sorako
Mori, Ryusaburo
Onoe, Hajime
Tanaka, Koji
Wakatsuki, Yu
Itagaki, Kanako
Kasai, Akihito
Ogasawara, Masashi
Sekiryu, Tetsuju
Shintake, Hiroaki
Sugano, Yukinori
author_sort Maruko, Ichiro
collection PubMed
description
format Online
Article
Text
id pubmed-8380561
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-83805612021-09-08 Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study Maruko, Ichiro Okada, Annabelle A. Iida, Tomohiro Hasegawa, Taiji Izumi, Takahiko Kawai, Moeko Maruko, Ruka Nakayama, Makiko Yamamoto, Akiko Koizumi, Hideki Tamashiro, Tamaki Terao, Nobuhiro Wakugawa, Sorako Mori, Ryusaburo Onoe, Hajime Tanaka, Koji Wakatsuki, Yu Itagaki, Kanako Kasai, Akihito Ogasawara, Masashi Sekiryu, Tetsuju Shintake, Hiroaki Sugano, Yukinori Graefes Arch Clin Exp Ophthalmol Letter to the Editor Springer Berlin Heidelberg 2021-03-15 2021 /pmc/articles/PMC8380561/ /pubmed/33723637 http://dx.doi.org/10.1007/s00417-021-05136-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Maruko, Ichiro
Okada, Annabelle A.
Iida, Tomohiro
Hasegawa, Taiji
Izumi, Takahiko
Kawai, Moeko
Maruko, Ruka
Nakayama, Makiko
Yamamoto, Akiko
Koizumi, Hideki
Tamashiro, Tamaki
Terao, Nobuhiro
Wakugawa, Sorako
Mori, Ryusaburo
Onoe, Hajime
Tanaka, Koji
Wakatsuki, Yu
Itagaki, Kanako
Kasai, Akihito
Ogasawara, Masashi
Sekiryu, Tetsuju
Shintake, Hiroaki
Sugano, Yukinori
Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study
title Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study
title_full Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study
title_fullStr Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study
title_full_unstemmed Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study
title_short Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study
title_sort brolucizumab-related intraocular inflammation in japanese patients with age-related macular degeneration: a short-term multicenter study
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380561/
https://www.ncbi.nlm.nih.gov/pubmed/33723637
http://dx.doi.org/10.1007/s00417-021-05136-w
work_keys_str_mv AT marukoichiro brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT okadaannabellea brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT iidatomohiro brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT hasegawataiji brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT izumitakahiko brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT kawaimoeko brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT marukoruka brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT nakayamamakiko brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT yamamotoakiko brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT koizumihideki brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT tamashirotamaki brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT teraonobuhiro brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT wakugawasorako brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT moriryusaburo brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT onoehajime brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT tanakakoji brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT wakatsukiyu brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT itagakikanako brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT kasaiakihito brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT ogasawaramasashi brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT sekiryutetsuju brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT shintakehiroaki brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT suganoyukinori brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy
AT brolucizumabrelatedintraocularinflammationinjapanesepatientswithagerelatedmaculardegenerationashorttermmulticenterstudy